Moreover, the utilization of a c-Myc inhibitor mitigated the proliferation of lung cancer cells induced by GATA6 silencing (Fig. 6I), concurrently inhibiting the upregulation of mRNA expression of genes associated with glucose metabolism induced by GATA6 silencing (Fig. 6J, k). The gene discussed is MYC; the disease is lung carcinoma.